NewsEvents

Your Yourlocation: Home > Effect of long-term combined use of tiotropium bromide(136310-93-5) powder and salmeterol on the patients with chronic obstructive pulmonary disease in stable stage and the prognosis

To observe the effect of tiotropium bromide(136310-93-5) and salmeterol on the efficacy and prognosis of chronic obstructive pulmonary disease (COPD) in middle-aged and elderly patients with severe or severe stabilization. The results showed that the combination of tiotropium and salmeterol in the treatment of severe COPD patients with severe COPD had a significantly better effect than tiotropium on pulmonary function, exercise tolerance and quality of life. No significant increase in adverse reactions. The article published on the Journal of Chinese Journal of Geriatrics.

Eighty patients with stable COPD were randomly divided into two groups. One group was treated with tiotropium bromide(136310-93-5) and one was treated with tiotropium bromide(136310-93-5) alone. Month. At 1, 3, 6, and 12 months after treatment, the patients were evaluated for lung function, 6-minute walk test, St. George questionnaire, and the number of acute exacerbations were recorded.

The pulmonary function index, 6 - minute walk test and St. George 's questionnaire score of the two groups after treatment were significantly improved (P <0.05). Compared with the single drug group, the combined group of indicators to improve more significantly (P <0.05).

Address: TEL:0531-82375879 Tiotropium Bromide
© Copyright(C)2014 JINAN DEXINJIA BIO & TECH CO., LTD All Rights Reserved